ERBB2 and neoplasm: Several preclinical studies have revealed the capability of HER2‐driven signaling to promote glucose uptake, oxygen consumption, overexpression of lactate dehydrogenase‐A (LDH‐A), and lactate production in tumor cells (Walsh et al., 2013; Zhao et al., 2009).